
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4669317
[patent_doc_number] => 20080044377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine'
[patent_app_type] => utility
[patent_app_number] => 10/575928
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13371
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575928 | Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine | Oct 14, 2004 | Abandoned |
Array
(
[id] => 5569376
[patent_doc_number] => 20090252754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses'
[patent_app_type] => utility
[patent_app_number] => 10/574751
[patent_app_country] => US
[patent_app_date] => 2004-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 20508
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574751 | Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses | Oct 10, 2004 | Abandoned |
Array
(
[id] => 5253311
[patent_doc_number] => 20070134767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Hiv-dependent expression constructs and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/574031
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12943
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574031 | Hiv-dependent expression constructs and uses therefor | Sep 27, 2004 | Abandoned |
Array
(
[id] => 7154213
[patent_doc_number] => 20050026213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Mammalian Galanin receptors'
[patent_app_type] => utility
[patent_app_number] => 10/946767
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10869
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026213.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946767
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946767 | Mammalian galanin receptors | Sep 21, 2004 | Issued |
Array
(
[id] => 5056759
[patent_doc_number] => 20070059681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Method for production of bioresorable microparticles, microparticles thus obtained and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/570948
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14876
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570948 | Method for production of bioresorable microparticles, microparticles thus obtained and use thereof | Sep 20, 2004 | Abandoned |
Array
(
[id] => 5688232
[patent_doc_number] => 20060286547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Time-of-addition assay for identifying anti-viral compounds'
[patent_app_type] => utility
[patent_app_number] => 10/570358
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9585
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570358 | Time-of-addition assay for identifying anti-viral compounds | Sep 19, 2004 | Abandoned |
Array
(
[id] => 7688933
[patent_doc_number] => 20070105765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells'
[patent_app_type] => utility
[patent_app_number] => 10/570487
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4278
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570487 | Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells | Sep 8, 2004 | Abandoned |
Array
(
[id] => 204260
[patent_doc_number] => 07629114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Method of collecting nasopharyngeal cells and secretions for diagnosis of viral upper respiratory infections and screening for nasopharyngeal cancer'
[patent_app_type] => utility
[patent_app_number] => 10/923444
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 6193
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923444 | Method of collecting nasopharyngeal cells and secretions for diagnosis of viral upper respiratory infections and screening for nasopharyngeal cancer | Aug 19, 2004 | Issued |
Array
(
[id] => 4977916
[patent_doc_number] => 20070219149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity'
[patent_app_type] => utility
[patent_app_number] => 10/567766
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12605
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567766 | Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity | Aug 9, 2004 | Abandoned |
Array
(
[id] => 7215985
[patent_doc_number] => 20050054601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccination'
[patent_app_type] => utility
[patent_app_number] => 10/894655
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8095
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894655 | Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccination | Jul 15, 2004 | Abandoned |
Array
(
[id] => 7126914
[patent_doc_number] => 20050058658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Compositions and methods for immunotherapy of human immunodeficiency virus (HIV)'
[patent_app_type] => utility
[patent_app_number] => 10/893581
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 55577
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893581
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893581 | Compositions and methods for immunotherapy of human immunodeficiency virus (HIV) | Jul 14, 2004 | Abandoned |
Array
(
[id] => 7275061
[patent_doc_number] => 20040234512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods for regualting hematopoiesis using CpG-oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/877369
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26422
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877369 | Methods for regualting hematopoiesis using CpG-oligonucleotides | Jun 24, 2004 | Abandoned |
Array
(
[id] => 7275684
[patent_doc_number] => 20040235135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/872706
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 18015
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235135.pdf
[firstpage_image] =>[orig_patent_app_number] => 10872706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/872706 | Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof | Jun 20, 2004 | Abandoned |
Array
(
[id] => 7211276
[patent_doc_number] => 20050053977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Methods for treating lentivirus infections'
[patent_app_type] => utility
[patent_app_number] => 10/865663
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28085
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865663 | Methods for treating lentivirus infections | Jun 8, 2004 | Issued |
Array
(
[id] => 7126910
[patent_doc_number] => 20050058654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Apoptosis-inducing polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/863637
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6541
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863637 | Apoptosis-inducing polypeptides | Jun 7, 2004 | Issued |
Array
(
[id] => 7372102
[patent_doc_number] => 20040219164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Advanced antigen presentation platform'
[patent_app_type] => new
[patent_app_number] => 10/857733
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11863
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219164.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857733
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857733 | Advanced antigen presentation platform | May 31, 2004 | Issued |
Array
(
[id] => 400979
[patent_doc_number] => 07291342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-06
[patent_title] => 'Infectious bronchitis virus vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/848589
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3745
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/291/07291342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848589
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848589 | Infectious bronchitis virus vaccine | May 16, 2004 | Issued |
Array
(
[id] => 5564061
[patent_doc_number] => 20090136914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests'
[patent_app_type] => utility
[patent_app_number] => 10/556563
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25286
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556563 | Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests | May 13, 2004 | Issued |
Array
(
[id] => 5046524
[patent_doc_number] => 20070265198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/556359
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19643
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265198.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556359 | Nucleic acids and polypeptides of C1 bacteriophage and uses thereof | May 13, 2004 | Issued |
Array
(
[id] => 7033130
[patent_doc_number] => 20050031639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Materials and methods for immunizing against FIV infection'
[patent_app_type] => utility
[patent_app_number] => 10/844658
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11356
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844658 | Materials and methods for immunizing against FIV infection | May 11, 2004 | Abandoned |